Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 493, pseudogene (RN7SL493P) is a pseudogene derived from the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP) complex[1][3][5]. The 7SL RNA is a crucial non-coding RNA involved in targeting secretory proteins to the endoplasmic reticulum via the SRP pathway, but RN7SL493P itself is classified as a processed pseudogene and does not encode a functional product[1][5]. The presence of numerous 7SL pseudogenes in the human genome is due to retrotransposition events, leading to truncated, non-functional versions scattered throughout the genome[5]. Like other pseudogenes, RN7SL493P might have minimal or subtle regulatory activity, but no direct biological, therapeutic, or disease relevance is established for this specific locus[4][5][6]. It is not considered a therapeutic target, nor is it associated with any notable drug interactions or biomarker roles. If you need structured data for a functional 7SL RNA or the SRP pathway, let me know—this entry is strictly for the pseudogene form, which is not itself a receptor, enzyme, or drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 493, pseudogene (RN7SL493P).